| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/17/2002 | CA2413044A1 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives |
| 01/17/2002 | CA2413042A1 Phenylpyridazine derivatives and drugs containing the same |
| 01/17/2002 | CA2413035A1 Thrombin inhibitors comprising an aminoisoquinoline group |
| 01/17/2002 | CA2412848A1 New bispidine compounds and their use in the treatment of cardiac arrhythmias |
| 01/17/2002 | CA2412764A1 Stimulation of cellular regeneration and differentiation in the inner ear |
| 01/17/2002 | CA2412142A1 A combination of fbpase inhibitors and antidiabetic agents useful for the treatment of diabetes |
| 01/17/2002 | CA2411160A1 Colchinol derivatives as vascular damaging agents |
| 01/17/2002 | CA2409337A1 Novel cephalosporin compounds and process for preparing the same |
| 01/17/2002 | CA2409329A1 Novel cephalosporin compounds and process for preparing the same |
| 01/17/2002 | CA2405798A1 Pyrido¬2,3-d|pyrimidine and pyrimido¬4,5-d|pyrimidine nucleosides |
| 01/17/2002 | CA2380859A1 Anti-obesity material |
| 01/16/2002 | EP1172654A1 Diagnostic method based on the detection of the L1 adhesion molecule for ovarian and endometrial tumors |
| 01/16/2002 | EP1172443A1 Method for screening cysteine protease inhibitor |
| 01/16/2002 | EP1172360A1 Neurotrophin potentiators |
| 01/16/2002 | EP1172359A1 N-SUBSTITUTED-N'-SUBSTITUTED UREA DERIVATIVE AND USE THEREOF AS TNF-$g(a) PRODUCTION INHIBITOR |
| 01/16/2002 | EP1172358A1 N-substituted-n'-substituted urea derivative and medicinal compositions containing the same |
| 01/16/2002 | EP1172116A1 Pharmaceutical composition comprising anti-H.pylori urease IgY antibodies and an inhibitor of gastric acid secretion |
| 01/16/2002 | EP1172115A1 Hemostatic soluble cellulose fibers containing coagulating protein for treating wound and process for producing the same |
| 01/16/2002 | EP1172112A2 Preventive, alleviative or remedy for hypertension |
| 01/16/2002 | EP1172110A2 Use of lipoic acid as a bioavailaty enhancer of mineral salts |
| 01/16/2002 | EP1172109A1 Compositions for preventing and treating type i allergy |
| 01/16/2002 | EP1172108A1 Novel immunosuppressants |
| 01/16/2002 | EP1172107A1 Drugs containing sulfopyranosylacylglycerol derivatives |
| 01/16/2002 | EP1172106A2 Use of fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles as substance P receptor antagonists |
| 01/16/2002 | EP1172105A1 Antifungal compositions |
| 01/16/2002 | EP1172104A1 Seam soft capsule preparations containing dihydrobenzofuran derivative |
| 01/16/2002 | EP1172103A2 Combination of 3-iodo-2-propynyl-butylcarbamate esters and one or more hydroxybenzoic acids |
| 01/16/2002 | EP1172102A2 Combination of 3-iodo-2-propynyl-butylcarbamate esters and one or more hydroxybenzoic acids and phenoxyethanol |
| 01/16/2002 | EP1172101A1 The use of nimesulide for the treatment of psoriasis and psoriatic arthritis |
| 01/16/2002 | EP1172100A1 Oral solid pharmaceutical formulations with ph-dependent multiphasic release |
| 01/16/2002 | EP1172098A1 Pharmaceutical compositions comprising ketotifen |
| 01/16/2002 | EP1172094A1 Composition, particularly for cosmetics, comprising DHEA and/or precursor or derivative, and at least a compound which increases the synthesis of glycosaminoglycans |
| 01/16/2002 | EP1172091A1 Skin dyeing compositions containing flavylium salt compounds non substituted in position 3 |
| 01/16/2002 | EP1172086A1 Active substance combinations based on 3-iodo-2-propinyl-butylcarbamate and phenoxyethanol and compositons containing them |
| 01/16/2002 | EP1172080A1 Vitamins and mineral salts composition to reduce the hairloss and/or to promote the hairregrowth |
| 01/16/2002 | EP1172041A2 Compositions of plant carbohydrates as dietary supplements |
| 01/16/2002 | EP1171595A1 13 transmembrane protein expressed in prostate cancer |
| 01/16/2002 | EP1171586A2 Methods and compositions for inhibiting the function of polynucleotide sequences |
| 01/16/2002 | EP1171585A1 49 human secreted proteins |
| 01/16/2002 | EP1171583A2 A multi-plasmid method for preparing large libraries of polyketides and non-ribosomal peptides |
| 01/16/2002 | EP1171578A2 Pharmaceutical composition comprising pim-activated nkt cells, and therapeutic use thereof |
| 01/16/2002 | EP1171462A2 49 human secreted proteins |
| 01/16/2002 | EP1171448A2 Macrolide antiinfective agents |
| 01/16/2002 | EP1171447A2 Ketolide antibacterials |
| 01/16/2002 | EP1171446A2 Macrolide antiinfective agents |
| 01/16/2002 | EP1171444A1 Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines |
| 01/16/2002 | EP1171443A1 Bicyclic heteroaromatic compounds useful as lh agonists |
| 01/16/2002 | EP1171442A1 Xanthine derivatives and analogs as cell signalling inhibitors |
| 01/16/2002 | EP1171441A1 Morphinoid compounds |
| 01/16/2002 | EP1171440A1 Substituted-3-cyano-[1.7],[1.5], and [1.8]-naphthyridine inhibitors of tyrosine kinases |
| 01/16/2002 | EP1171439A1 Azaindole derivatives for the treatment of depression |
| 01/16/2002 | EP1171438A1 Compounds, their preparation and use |
| 01/16/2002 | EP1171435A2 Pyrimidine-2-one derivatives as integrin receptor ligands |
| 01/16/2002 | EP1171432A1 Adamantane derivatives |
| 01/16/2002 | EP1171431A1 Compounds, their preparation and use |
| 01/16/2002 | EP1171430A1 Novel polymorphic forms of an antidiabetic agent: process for their preparation and pharmaceutical compositions containing them |
| 01/16/2002 | EP1171428A1 Fab i inhibitors |
| 01/16/2002 | EP1171425A1 Use of maduraphthalazine derivatives as inhibitors of pro-inflammatory cytokins |
| 01/16/2002 | EP1171424A1 Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors |
| 01/16/2002 | EP1171423A1 Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands |
| 01/16/2002 | EP1171422A1 Mmp inhibitor |
| 01/16/2002 | EP1171419A1 Biphenyl derivatives as antagonists of the neurokinine-1 receptor |
| 01/16/2002 | EP1171416A1 3-bicycloaryl-2-aminomethyl bicycloalkanes as serotonine reuptake inhibitors |
| 01/16/2002 | EP1171414A1 Compounds, their preparation and use |
| 01/16/2002 | EP1171203A2 Medicaments containing doxazosin-mesylate of crystalline modification d |
| 01/16/2002 | EP1171165A1 Intramyocardial injection of autologous bone marrow |
| 01/16/2002 | EP1171163A1 Compositions containing tetracyclines for treating hemorrhagic virus infections and other disorders |
| 01/16/2002 | EP1171162A2 Cobalamin conjugates useful as antitumor agents |
| 01/16/2002 | EP1171161A1 Treatment of adult rheumatoid arthritis by oral administration of pooled human immunoglobulin and an antacid |
| 01/16/2002 | EP1171159A2 Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (rsv) |
| 01/16/2002 | EP1171156A1 Novel use within transplantation surgery |
| 01/16/2002 | EP1171155A2 Therapeutic compositions and methods for enhancing angiogenesis |
| 01/16/2002 | EP1171154A2 Uses of mammalian ox2 protein and related reagents |
| 01/16/2002 | EP1171151A1 Thrombospondin-2 and uses thereof |
| 01/16/2002 | EP1171150A2 Pseudomycin antifungal compositions and methods for their use |
| 01/16/2002 | EP1171146A1 Pharmaceutical compositions containing selegiline and ginkgo biloba extract useful for dementia |
| 01/16/2002 | EP1171145A1 Use of catechin for preventing or treating coronary restenosis |
| 01/16/2002 | EP1171144A1 Use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa |
| 01/16/2002 | EP1171138A2 Use of 6-methylmercaptopurine riboside in ophthalmologic compositions |
| 01/16/2002 | EP1171137A1 Methods of treatment of mitochondrial disorders |
| 01/16/2002 | EP1171136A2 Immunomodulating composition for use especially in the treatment of inflammations, infections and surgical adhesions |
| 01/16/2002 | EP1171135A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 01/16/2002 | EP1171134A1 Controlled release of sildenafil delivered by sublingual or buccal administration |
| 01/16/2002 | EP1171133A2 R-hydroxynefazodone |
| 01/16/2002 | EP1171132A1 Injectable naltrexone microsphere compositions and their use in reducing consumption of heroin and alcohol |
| 01/16/2002 | EP1171131A1 Medicaments containing inhibitors of cell-volume regulated human kinase h-sgk |
| 01/16/2002 | EP1171130A1 Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same |
| 01/16/2002 | EP1171129A1 Use of glucosylceramide synthesis inhibitors in therapy |
| 01/16/2002 | EP1171128A1 Combination of glucosylceramide synthesis inhibitors and glycolipid degrading enzyme in therapy |
| 01/16/2002 | EP1171127A2 Pharmaceutical compositions containing pyridine or pyrimidine derivatives for inhibition of cytokine production and secretion |
| 01/16/2002 | EP1171125A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 01/16/2002 | EP1171124A2 Anthelmintic compositions |
| 01/16/2002 | EP1171123A1 Method for treating neurodegeneration |
| 01/16/2002 | EP1171122A1 Pyrrolidine modulators of chemokine receptor activity |
| 01/16/2002 | EP1171121A2 Pharmaceutical compositions comprising dipeptidylpeptidase iv inhibitors for the promotion of growth |
| 01/16/2002 | EP1171120A1 Methods for alleviating discomfort of a hot flash and compositions therefor |
| 01/16/2002 | EP1171119A1 Methods of treating clinical diseases with isoflavones |
| 01/16/2002 | EP1171118A2 Methods and compositions for enhancing delivery of therapeutic agents to tissues |
| 01/16/2002 | EP1171117A1 Long term administration of pharmacologically active agents |
| 01/16/2002 | EP1171116A1 Method for the prevention or reduction of cariovascular events associated with coronary intervention |